Episodios

  • Mo Li on PARP inhibitors
    Jul 4 2024

    Dr. Mo Li from Peking University Third Hospital discusses his publication "PARP inhibitors suppress tumours via centrosome error-induced senescence independent of DNA damage response".

    Read the full article:
    https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(24)00164-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_ebiom

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Más Menos
    16 m
  • Sanja Jelic & Daniel Gottlieb on the impact of CPAP on biomarkers
    May 30 2024

    Sanja Jelic & Daniel Gottlieb join eBioMedicine to discuss the use of continuous positive airway pressure in obstructive sleep apnoea and its impact on cardiovascular and inflammatory markers.

    Read the full article:
    https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(24)00050-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_ebiom

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Más Menos
    18 m
  • Eddy Pasquier & Marion LeGrand on druggable cancer vulnerabilities
    Nov 7 2023

    Drs. Pasquier and LeGrand join eBioMedicine to discuss their stepwise approach to unveil druggable cancer vulnerabilities and to fast-track the identification of synergistic combinations against glioblastoma.

    Read the full article:
    https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(23)00317-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_ebiom

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Más Menos
    13 m
  • Alan Dangour on climate change and health
    Sep 25 2023

    Alan Dangour joins eBioMedicine to discuss climate change and health, our recently published Series, and projects they are working on at The Wellcome Trust.

    Read the full Series:
    https://www.thelancet.com/series/climate-change-and-health?dgcid=buzzsprout_icw_podcast_generic_ebiom

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Más Menos
    16 m
  • John Cryan on the microbiome-gut-brain axis and binge drinking
    Jul 25 2023

    John Cryan joins eBioMedicine to discuss how the microbiome-gut-brain axis regulates social cognition and craving in young binge drinkers.

    Read the full article:
    https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(23)00007-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_ebiom

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Más Menos
    22 m
  • Alvaro Berbís & David McClintock on computational pathology in 2030
    May 4 2023

    Drs Berbís and McClintock join eBioMedicine to discuss the survey they conducted with experts, forecasting the role of AI in pathology within the next decade.

    Read the full article:
    https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(22)00609-0/fulltext?dgcid=buzzsprout_icw_podcast_ebiom_lancet

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Más Menos
    13 m
  • Peter Robinson and Justin Reese on Long COVID subtypes
    Feb 24 2023

    Drs Robinson and Reese join eBioMedicine to discuss their findings on semantic phenotypic clustering long COVID subtypes observed in N3C and RECOVER programmes.

    Read the full article:
    Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Más Menos
    22 m
  • Ke-Wu Zeng on molecular glues for cancer therapy
    Jan 18 2023

    Drs Zeng join eBioMedicine to discuss their study of a novel molecular glue, called bufalin.

    Read the full article:
    Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Más Menos
    14 m